M&A Deal Summary |
|
|---|---|
| Date | 2014-09-09 |
| Target | Xetrios Therapeutics |
| Sector | Life Science |
| Buyer(s) | Kolltan Pharmaceuticals |
| Deal Type | Add-on Acquisition |
SEARCH BY
| Category | Company |
|---|---|
| Founded | 2007 |
| Sector | Life Science |
Kolltan Pharmaceuticals, Inc. is a privately held biopharmaceutical company focused on the discovery and development of novel antibody-based drugs targeting receptor tyrosine kinases (RTKs).
| DEAL STATS | # |
|---|---|
| Overall | 1 of 1 |
| Sector: Life Science M&A | 1 of 1 |
| Type: Add-on Acquisition M&A Deals | 1 of 1 |
| State: California M&A | 1 of 1 |
| Country: United States M&A | 1 of 1 |
| Year: 2014 M&A | 1 of 1 |
